Filing Details

Accession Number:
0001161697-22-000550
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-11-15 17:01:17
Reporting Period:
2022-11-11
Accepted Time:
2022-11-15 17:01:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1369568 Catalyst Pharmaceuticals Inc. CPRX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1872422 Preethi Sundaram 355 Alhambra Circle
Suite 801
Coral Gables FL 33134
Chief Strategy Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.001 Per Share Acquisiton 2022-11-11 56,786 $5.49 56,786 No 4 M Direct
Common Stock, Par Value $0.001 Per Share Disposition 2022-11-11 28,393 $16.25 28,393 No 4 S Direct
Common Stock, Par Value $0.001 Per Share Disposition 2022-11-11 28,393 $16.50 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Options to purchase common stock Disposition 2022-11-11 56,786 $0.00 56,786 $5.49
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
342,500 2022-07-06 2028-07-06 No 4 M Direct
Footnotes
  1. Shares were sold for personal reasons and not as a result of any disagreement with the Registrant. Dr. Sundaram remains an officer of the Company.